News | PET Imaging | November 20, 2026

Strategic collaboration aims to accelerate standardization, reproducibility, and clinical adoption of quantitative molecular imaging worldwide

SNMMI, QMIC Team Up to Advance Quantitative PET, SPECT Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Quantitative Medical Imaging Coalition (QMIC) have signed a Memorandum of Understanding (MoU) establishing a long-term collaboration to advance quantitative PET and SPECT imaging. The partnership combines the complementary expertise of both organizations to advance the standardization, reproducibility, and clinical implementation of quantitative imaging in multicenter clinical trials and routine clinical practice.

The collaboration aims to strengthen the role of quantitative molecular imaging by promoting harmonized approaches to image acquisition, reconstruction, processing, analysis, and reporting. Through the development and implementation of shared standards and guidelines, SNMMI and QMIC seek to improve the accuracy, consistency, and reproducibility of quantitative imaging results across scanners, institutions, and clinical studies.

A Shared Commitment 

Under the MoU, the organizations will focus on several key areas of collaboration:

  • Standardized imaging guidelines: Developing harmonized guidelines for PET/CT and SPECT/CT image acquisition, documentation, processing, and analysis, in the context of multicenter clinical trials and clinical practice.

  • Quantitative imaging biomarkers: Advancing the development, validation, and clinical implementation of quantitative PET/CT and SPECT/CT imaging biomarkers for clinical research and patient care.

  • Scanner and site network: Establishing a network of PET/CT and SPECT/CT scanners and clinical sites capable of meeting harmonized quantitative imaging requirements, supported by standardized scanner validation and calibration procedures.

  • Biomarker harmonization: Developing standards and guidelines for quantifying PSMA Total Tumor Volume in PSMA PET and Metabolic Tumor Volume in FDG PET, as well as related imaging biomarkers using other radiotracers.

A particular focus of the collaboration will be the continued development and refinement of quantitative PET/CT guidelines through engagement between SNMMI's scientific community and QMIC's PET/CT Biomarker Committees, including the Tau PET and FDG-PET/CT Biomarker Committees.

By combining SNMMI’s expertise in scanner validation, calibration, and quantitative image acquisition with QMIC’s work on quantitative imaging biomarkers and standardized image analysis, the collaboration will help bridge the gap between technical standardization and practical implementation across clinical sites.

Quantitative PET and SPECT imaging

Quantitative PET and SPECT imaging offer important opportunities to move beyond qualitative image interpretation toward more objective and reproducible measurements of disease. However, realizing their full potential requires harmonized methodologies, validated imaging systems, and consistent technical standards across clinical sites.

By combining their complementary expertise and working toward common standards, SNMMI and QMIC aim to improve the reliability and comparability of quantitative imaging biomarkers and measures to strengthen multicenter research and support their broader implementation in clinical practice.

 

SNMMI PET Imaging MOU

 


Additional Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
Subscribe Now